Endometrial cancer (EC) ranks as the second most prevalent gynecologic malignancy globally, with approximately 189,000 new ...

Shakeya Allen was 27 years old when she felt something was not right with her health. A miscarriage would lead to her diagnosis. “They said, ‘Don’t worry. Women under 40 do not get uterine cancer.

在全球范围内，子宫内膜癌（Endometrial Cancer，EC）成为发达国家最常见的妇科恶性肿瘤之一，其发病率正持续攀升，严重威胁着女性健康。尽管早期EC患者经过手术治疗后的5年生存率可高达80%至90%，但若肿瘤扩散至局部或远处，其生存率会骤降至68%及17%。为了改善这一状况，迫切需要探索新的诊疗策略。

The US Food and Drug Administration (FDA) has granted breakthrough device designation for Acrivon Therapeutics’ ACR-368 ...

Endometrial cancer starts in the tissue that lines your uterus. If the cancer is platinum-resistant, platinum-based chemotherapy drugs will not work well to kill it or stop it from returning after ...

Managing endometrial cancer can be very stressful. Taking steps to support your emotional and mental health is important for improving your quality of life with this condition. An endometrial ...

"The lack of a significant link between AmygA and LN metastasis in premenopausal women suggests that menopausal status may ...

National Cancer Awareness Month provides an opportunity for the medical community to spotlight the ongoing battle against one ...

Acrivon has developed AP3 Interactome, a proprietary, computational analytics platform driven by machine learning for integrated comprehensive analyses across all large, in-house AP3 phosphoproteomic ...

Acrivon Therapeutics said the Food and Drug Administration has granted Breakthrough Device designation for its ACR-368 OncoSignature assay, an immunofluorescence assay for the identification of ...